0001104659-21-108575.txt : 20210823 0001104659-21-108575.hdr.sgml : 20210823 20210823161549 ACCESSION NUMBER: 0001104659-21-108575 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210823 DATE AS OF CHANGE: 20210823 EFFECTIVENESS DATE: 20210823 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-410958 FILM NUMBER: 211197016 BUSINESS ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 781-788-9043 MAIL ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 D 1 primary_doc.xml X0708 D LIVE 0001372514 EYEGATE PHARMACEUTICALS INC 271 WAVERLEY OAKS ROAD, SUITE 108 WALTHAM MA MASSACHUSETTS 02452 781-788-9043 DELAWARE None None Corporation true Brian Strem 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer Director President and Chief Executive Officer Sarah Romano 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer Chief Financial Officer Stephen From 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer Director Executive Chairman Paul Chaney 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Aron Shapiro 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Kenneth Gayron 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Praveen Tyle 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Pharmaceuticals Decline to Disclose 06b false 2021-08-09 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 FL FLORIDA IL ILLINOIS NV NEVADA NJ NEW JERSEY NY NEW YORK TX TEXAS false 10750013 10750013 0 This amount includes proceeds from the sale of common shares pursuant to a separate registered direct offering, as well as the warrants covered by this filing. The amount does not include proceeds from the exercise of warrants. false 14 860001 0 H.C. Wainwright & Co., LLC also received warrants to purchase 233,442 warrants of common stock. The compensation also covers the sale of common stock in the concurrent registered direct offering, as well as the warrants covered by this filing. 0 Some of the proceeds may be used for working captial and other general corporate purposes, which may include the payment of salaries and other fees to those listed in item 3. false EYEGATE PHARMACEUTICALS INC /s/ Sarah Romano Sarah Romano Chief Financial Officer 2021-08-23